Arthrex® AR-1934BCF-24Recalls & reported problems
Arthrex, Inc. · BIO-COMP S-TAK,2.4X12MM · Class 2 · Implant
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00888867023901), received between Aug 16, 2016 and Aug 21, 2025 — classified as 1 injury, 1 malfunction.
The most frequently reported specific device problem is “Break” (2 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Reports received per month
Most reported problems
Device problems
- Break2
- Detachment Of Device Component1
- Difficult to Remove1
- Entrapment of Device1
Patient problems
- No Clinical Signs, Symptoms or Conditions1
- No Known Impact Or Consequence To Patient1
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
MalfunctionAug 21, 2025Break; Break
ON (B)(6) 2025, AN ARTHREX SUBSIDIARY EMPLOYEE REPORTED VIA EMAIL AN ISSUE INVOLVING AN AR-1934BCF-24 2.4 MM BIOCOMPOSITE SUTURETAK FRACTURE IN HALF. DURING THE PROCEDURE, A 2.4 MM SUTURETAK ANCHOR WAS REQUESTED AND PLACED USING STANDARD SURGICAL TECHNIQUE, WHICH INCLUDED DRILLING WITH A 2.4 MM BIT AND IMPLANT IMPACTION. UPON INSERTION, THE IMPLANT FRACTURED IN HALF AT THE ANCHOR. IT WAS NOTED THAT A PREVIOUS IMPLANT OF THE SAME TYPE HAD BEEN PLACED WITHOUT ISSUE. PRIOR TO PLACEMENT, THE IMPLANT STEM APPEARED SOMEWHAT UNSTABLE; HOWEVER, INSERTION WAS STILL ATTEMPTED FOLLOWING ALL RECOMMENDED STEPS. A THIRD IMPLANT WAS SUBSEQUENTLY PLACED AND FUNCTIONED CORRECTLY. THE INCIDENT OCCURRED ON 7/14/2025 DURING A COLLATERAL LIGAMENT RECONSTRUCTION PROCEDURE. ADDITIONAL INFORMATION WAS RECEIVED ON 08/13/2025: ALL FRAGMENTS OF THE AR-1934BCF-24 2.4 MM BIOCOMPOSITE SUTURETAK WERE RETRIEVED. THE CASE WAS COMPLETED USING A REPLACEMENT AR-1934BCF-24 FROM LOT NUMBER 15044246. NO PROCEDURAL DELAYS WERE REPORTED, AND NO ADDITIONAL ANESTHESIA WAS ADMINISTERED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 22866245 ↗InjuryAug 16, 2016Break; Detachment Of Device Component; Entrapment of Device; Difficult to Remove
IT WAS REPORTED THAT DURING AN ORIF RIGHT ELBOW CORONOID FRACTURE REPAIR, THE BIO-COMPOSITE SUTURETAK SUTURE ANCHOR BROKE ON INSERTION. THE SURGEON ATTEMPTED MULTIPLE TIMES TO REMOVE THE ANCHOR BUT WAS NOT ABLE TO DO SO. NO PATIENT INJURY REPORTED.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 5878365 ↗
Other FASTENER, FIXATION, BIODEGRADABLE, SOFT TISSUE devices
- GRYPHON ORTHOCORD 210813Medos International Sàrl · FASTENER, FIXATION, BIODEGRADABLE, SOFT TISSUE712 reports
- HEALIX ADVANCE 222330Depuy Mitek, LLC · FASTENER, FIXATION, BIODEGRADABLE, SOFT TISSUE1 recall607 reports
- HEALIX ADVANCE ORTHOCORD 222295Medos International Sàrl · FASTENER, FIXATION, BIODEGRADABLE, SOFT TISSUE640 reports
- HEALICOIL 72205137Smith & Nephew, Inc. · Fastener, fixation, biodegradable, soft tissue427 reports
- HEALIX ADVANCE ORTHOCORD 222296Medos International Sàrl · FASTENER, FIXATION, BIODEGRADABLE, SOFT TISSUE320 reports
- TWINFIX 72202597Smith & Nephew, Inc. · FASTENER, FIXATION, BIODEGRADABLE, SOFT TISSUE288 reports
- Arthrex® AR-2324BCCArthrex, Inc. · FASTENER, FIXATION, BIODEGRADABLE, SOFT TISSUE254 reports
- HEALIX ADVANCE 222331Depuy Mitek, LLC · FASTENER, FIXATION, BIODEGRADABLE, SOFT TISSUE1 recall196 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page